Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana-Reference-Cited by-同舟云学术

Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana

Published:2021-06 Issue:6 Volume:24 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Int AIDS Soc

Author:

Zash Rebecca¹²³^ORCID,Caniglia Ellen C⁴,Diseko Modiegi²,Mayondi Gloria²,Mabuta Judith²,Luckett Rebecca¹²⁵,Hofmeyr G Justus⁵,Morroni Chelsea²⁶,Ramogola‐Masire Doreen⁵,Williams Paige L³,Zera Chloe¹,Wylie Blair J¹,Makhema Joseph²,Lockman Shahin²³⁷,Shapiro Roger L²⁶

Affiliation:

1. Beth Israel Deaconess Medical Center Boston MA USA

2. Botswana‐Harvard AIDS Institute Partnership Gaborone Botswana

3. Harvard T.H. Chan School of Public Health Boston MA USA

4. New York University School of Medicine New York NY USA

5. University of Botswana Gaborone Botswana

6. Liverpool School of Tropical Medicine Liverpool UK

7. Brigham and Women’s Hospital Boston MA USA

Funder

Doris Duke Charitable Foundation

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute of Allergy and Infectious Diseases

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.25763

Reference42 articles.

1. Dolutegravir-Based or Low-Dose Efavirenz–Based Regimen for the Treatment of HIV-1

2. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

3. BedimoR Adams‐HuetB XilongL et al.Integrase inhibitor‐based HAART is associated with greater BMI gains in blacks hispanics and women. Presented at IDWeek 2018 San Francisco CA Oct 3‐7. Abstract 528.

4. BedimoR LiX Adams‐HuetB LakeJE TaylorBS KimD et al.Differential BMI changes following PI‐ and InSTI‐based ART initiation by sex and race. Presented at CROI 2019 Seattle WA. Abstract 675.

5. LakeJE WuK ErlandsonKM BaresSH DebroyP GodfreyC et al.Risk factors for excess weight gain following switch to integrase inhibitor‐based ART. Presented at CROI 2019 Seattle WA. Abstract 669.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa;Journal of the International AIDS Society;2024-07

2. Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts;The Lancet HIV;2024-05

3. Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis;Frontiers in Medicine;2024-02-27

4. Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens;Open Forum Infectious Diseases;2024-01-24

5. Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum;Clinical Infectious Diseases;2024-01-05